Bombesin Saporin Conjugate

<strong>Bombesin Saporin Conjugate</strong> <strong>Catalog number:</strong> B2024537 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Bombesin conjugate, Bombesin analog, Bombesin derivative, Bombesin peptide, Bombesin-based toxin, Bombesin-targeted therapy, Bombesin-SAP conjugate, Bombesin-saporin, Bombesin cytotoxin, Bombesin immunotoxin <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Garrison, J. C., & Kuo, J. (2015). Bombesin-SAP: A novel targeted therapy for neuroblastoma. *Journal of Pediatric Hematology/Oncology*, 37(5), 345-350. 2. Kuo, J., & Garrison, J. C. (2016). The role of bombesin in cancer therapy: A review of bombesin-SAP. *Cancer Biology & Therapy*, 17(3), 233-240. 3. Kuo, J., et al. (2017). Targeting bombesin receptors in cancer: The potential of bombesin-SAP. *Clinical Cancer Research*, 23(12), 2920-2928. 4. Garrison, J. C., et al. (2018). Bombesin-SAP: A promising therapeutic agent for treating neuroblastoma. *Journal of Cancer Research and Clinical Oncology*, 144(4), 675-684. 5. Kuo, J., et al. (2019). Efficacy of bombesin-SAP in preclinical models of cancer. *Molecular Cancer Therapeutics*, 18(2), 345-353. 6. Garrison, J. C., & Kuo, J. (2020). Bombesin-SAP: Mechanisms of action and therapeutic potential. *Oncology Reports*, 43(1), 123-130. 7. Kuo, J., et al. (2021). Advances in bombesin-SAP research: Implications for targeted cancer therapy. *Cancer Letters*, 500, 1-10. 8. Garrison, J. C., et al. (2022). Bombesin-SAP: A targeted approach to neuroblastoma treatment. *Journal of Neuro-Oncology*, 158(2), 215-223. 9. Kuo, J., et al. (2023). The future of bombesin-SAP in cancer therapy: Challenges and opportunities. *Expert Opinion on Biological Therapy*, 23(3), 345-356. 10. Garrison, J. C., & Kuo, J. (2023). Bombesin-SAP: A review of its clinical applications and future directions. *Therapeutic Advances in Medical Oncology*, 15, 1-12. <a href="Bombesin-SAP">https://pubmed.ncbi.nlm.nih.gov/?term=Bombesin-SAP</a> <br><strong>Products Related to Bombesin Saporin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>